๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Percutaneous cholecystostomy: A valuable technique in high-risk patients with presumed acute cholecystitis

โœ Scribed by M. M. Melin; Dr. M. G. Sarr; C. E. Bender; J. A. Van Heerden

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
494 KB
Volume
82
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Long-term ursodeoxycholic acid therapy i
Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: A cohort analysis
โœ Shinji Tomida; Masato Abei; Takashi Yamaguchi; Yasushi Matsuzaki; Junichi Shoda; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 80 KB ๐Ÿ‘ 1 views

Whether ursodeoxycholic acid (UDCA) therapy alters the long-term clinical course of gallstones (GS) without stone dissolution remains unknown. We aimed to clarify the relationship between long-term UDCA therapy and risks of biliary pain or acute cholecystitis in GS patients. We also aimed to identif

Randomized controlled trial of standard
Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding
โœ W. H. Chan; L. W. Khin; Y. F. A. Chung; Y. C. Goh; H. S. Ong; W. K. Wong ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB ๐Ÿ‘ 2 views

## Abstract ## Background Rebleeding from peptic ulcers is a major contributor to death. This study compared standard (40-mg intravenous infusion of omeprazole once daily for 3 days) and high-dose (80-mg bolus of omeprazole followed by 8-mg/h infusion for 72 h) in reducing the rebleeding rate (pri